According to our latest study, the global Computational Medicine and Drug Designing Software market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The publisher report includes an overview of the development of the Computational Medicine and Drug Designing Software industry chain, the market status of Drug Discovery and Development (Cloud-based, On-premise), Computational Physiological Medicine (Cloud-based, On-premise), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Computational Medicine and Drug Designing Software.
Regionally, the report analyzes the Computational Medicine and Drug Designing Software markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Computational Medicine and Drug Designing Software market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Computational Medicine and Drug Designing Software market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Computational Medicine and Drug Designing Software industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Cloud-based, On-premise).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Computational Medicine and Drug Designing Software market.
Regional Analysis: The report involves examining the Computational Medicine and Drug Designing Software market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Computational Medicine and Drug Designing Software market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Computational Medicine and Drug Designing Software:
Company Analysis: Report covers individual Computational Medicine and Drug Designing Software players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Computational Medicine and Drug Designing Software This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Drug Discovery and Development, Computational Physiological Medicine).
Technology Analysis: Report covers specific technologies relevant to Computational Medicine and Drug Designing Software. It assesses the current state, advancements, and potential future developments in Computational Medicine and Drug Designing Software areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Computational Medicine and Drug Designing Software market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Computational Medicine and Drug Designing Software market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Cloud-based
On-premise
Market segment by Application
Drug Discovery and Development
Computational Physiological Medicine
Disease Modeling
Medical Imaging
Predictive Analysis of Drug Targets
Market segment by players, this report covers
Entelos
Crown Bioscience
Chemical Computing Group
Nimbus Therapeutics
Schrodinger
Dassault Systemes
Genedata
Biognos
Leadscope
Rhenovia Pharma Limited
Compugen
Certara LP
Prosarix
Simulations Plus
Strand Life Sciences
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Computational Medicine and Drug Designing Software product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Computational Medicine and Drug Designing Software, with revenue, gross margin and global market share of Computational Medicine and Drug Designing Software from 2019 to 2024.
Chapter 3, the Computational Medicine and Drug Designing Software competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Computational Medicine and Drug Designing Software market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Computational Medicine and Drug Designing Software.
Chapter 13, to describe Computational Medicine and Drug Designing Software research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Computational Medicine and Drug Designing Software
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Computational Medicine and Drug Designing Software by Type
1.3.1 Overview: Global Computational Medicine and Drug Designing Software Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Computational Medicine and Drug Designing Software Consumption Value Market Share by Type in 2023
1.3.3 Cloud-based
1.3.4 On-premise
1.4 Global Computational Medicine and Drug Designing Software Market by Application
1.4.1 Overview: Global Computational Medicine and Drug Designing Software Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Drug Discovery and Development
1.4.3 Computational Physiological Medicine
1.4.4 Disease Modeling
1.4.5 Medical Imaging
1.4.6 Predictive Analysis of Drug Targets
1.5 Global Computational Medicine and Drug Designing Software Market Size & Forecast
1.6 Global Computational Medicine and Drug Designing Software Market Size and Forecast by Region
1.6.1 Global Computational Medicine and Drug Designing Software Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Computational Medicine and Drug Designing Software Market Size by Region, (2019-2030)
1.6.3 North America Computational Medicine and Drug Designing Software Market Size and Prospect (2019-2030)
1.6.4 Europe Computational Medicine and Drug Designing Software Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Computational Medicine and Drug Designing Software Market Size and Prospect (2019-2030)
1.6.6 South America Computational Medicine and Drug Designing Software Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Computational Medicine and Drug Designing Software Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Entelos
2.1.1 Entelos Details
2.1.2 Entelos Major Business
2.1.3 Entelos Computational Medicine and Drug Designing Software Product and Solutions
2.1.4 Entelos Computational Medicine and Drug Designing Software Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Entelos Recent Developments and Future Plans
2.2 Crown Bioscience
2.2.1 Crown Bioscience Details
2.2.2 Crown Bioscience Major Business
2.2.3 Crown Bioscience Computational Medicine and Drug Designing Software Product and Solutions
2.2.4 Crown Bioscience Computational Medicine and Drug Designing Software Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Crown Bioscience Recent Developments and Future Plans
2.3 Chemical Computing Group
2.3.1 Chemical Computing Group Details
2.3.2 Chemical Computing Group Major Business
2.3.3 Chemical Computing Group Computational Medicine and Drug Designing Software Product and Solutions
2.3.4 Chemical Computing Group Computational Medicine and Drug Designing Software Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Chemical Computing Group Recent Developments and Future Plans
2.4 Nimbus Therapeutics
2.4.1 Nimbus Therapeutics Details
2.4.2 Nimbus Therapeutics Major Business
2.4.3 Nimbus Therapeutics Computational Medicine and Drug Designing Software Product and Solutions
2.4.4 Nimbus Therapeutics Computational Medicine and Drug Designing Software Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Nimbus Therapeutics Recent Developments and Future Plans
2.5 Schrodinger
2.5.1 Schrodinger Details
2.5.2 Schrodinger Major Business
2.5.3 Schrodinger Computational Medicine and Drug Designing Software Product and Solutions
2.5.4 Schrodinger Computational Medicine and Drug Designing Software Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Schrodinger Recent Developments and Future Plans
2.6 Dassault Systemes
2.6.1 Dassault Systemes Details
2.6.2 Dassault Systemes Major Business
2.6.3 Dassault Systemes Computational Medicine and Drug Designing Software Product and Solutions
2.6.4 Dassault Systemes Computational Medicine and Drug Designing Software Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Dassault Systemes Recent Developments and Future Plans
2.7 Genedata
2.7.1 Genedata Details
2.7.2 Genedata Major Business
2.7.3 Genedata Computational Medicine and Drug Designing Software Product and Solutions
2.7.4 Genedata Computational Medicine and Drug Designing Software Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Genedata Recent Developments and Future Plans
2.8 Biognos
2.8.1 Biognos Details
2.8.2 Biognos Major Business
2.8.3 Biognos Computational Medicine and Drug Designing Software Product and Solutions
2.8.4 Biognos Computational Medicine and Drug Designing Software Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Biognos Recent Developments and Future Plans
2.9 Leadscope
2.9.1 Leadscope Details
2.9.2 Leadscope Major Business
2.9.3 Leadscope Computational Medicine and Drug Designing Software Product and Solutions
2.9.4 Leadscope Computational Medicine and Drug Designing Software Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Leadscope Recent Developments and Future Plans
2.10 Rhenovia Pharma Limited
2.10.1 Rhenovia Pharma Limited Details
2.10.2 Rhenovia Pharma Limited Major Business
2.10.3 Rhenovia Pharma Limited Computational Medicine and Drug Designing Software Product and Solutions
2.10.4 Rhenovia Pharma Limited Computational Medicine and Drug Designing Software Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Rhenovia Pharma Limited Recent Developments and Future Plans
2.11 Compugen
2.11.1 Compugen Details
2.11.2 Compugen Major Business
2.11.3 Compugen Computational Medicine and Drug Designing Software Product and Solutions
2.11.4 Compugen Computational Medicine and Drug Designing Software Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Compugen Recent Developments and Future Plans
2.12 Certara LP
2.12.1 Certara LP Details
2.12.2 Certara LP Major Business
2.12.3 Certara LP Computational Medicine and Drug Designing Software Product and Solutions
2.12.4 Certara LP Computational Medicine and Drug Designing Software Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Certara LP Recent Developments and Future Plans
2.13 Prosarix
2.13.1 Prosarix Details
2.13.2 Prosarix Major Business
2.13.3 Prosarix Computational Medicine and Drug Designing Software Product and Solutions
2.13.4 Prosarix Computational Medicine and Drug Designing Software Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Prosarix Recent Developments and Future Plans
2.14 Simulations Plus
2.14.1 Simulations Plus Details
2.14.2 Simulations Plus Major Business
2.14.3 Simulations Plus Computational Medicine and Drug Designing Software Product and Solutions
2.14.4 Simulations Plus Computational Medicine and Drug Designing Software Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Simulations Plus Recent Developments and Future Plans
2.15 Strand Life Sciences
2.15.1 Strand Life Sciences Details
2.15.2 Strand Life Sciences Major Business
2.15.3 Strand Life Sciences Computational Medicine and Drug Designing Software Product and Solutions
2.15.4 Strand Life Sciences Computational Medicine and Drug Designing Software Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Strand Life Sciences Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Computational Medicine and Drug Designing Software Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Computational Medicine and Drug Designing Software by Company Revenue
3.2.2 Top 3 Computational Medicine and Drug Designing Software Players Market Share in 2023
3.2.3 Top 6 Computational Medicine and Drug Designing Software Players Market Share in 2023
3.3 Computational Medicine and Drug Designing Software Market: Overall Company Footprint Analysis
3.3.1 Computational Medicine and Drug Designing Software Market: Region Footprint
3.3.2 Computational Medicine and Drug Designing Software Market: Company Product Type Footprint
3.3.3 Computational Medicine and Drug Designing Software Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Computational Medicine and Drug Designing Software Consumption Value and Market Share by Type (2019-2024)
4.2 Global Computational Medicine and Drug Designing Software Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Computational Medicine and Drug Designing Software Consumption Value Market Share by Application (2019-2024)
5.2 Global Computational Medicine and Drug Designing Software Market Forecast by Application (2025-2030)
6 North America
6.1 North America Computational Medicine and Drug Designing Software Consumption Value by Type (2019-2030)
6.2 North America Computational Medicine and Drug Designing Software Consumption Value by Application (2019-2030)
6.3 North America Computational Medicine and Drug Designing Software Market Size by Country
6.3.1 North America Computational Medicine and Drug Designing Software Consumption Value by Country (2019-2030)
6.3.2 United States Computational Medicine and Drug Designing Software Market Size and Forecast (2019-2030)
6.3.3 Canada Computational Medicine and Drug Designing Software Market Size and Forecast (2019-2030)
6.3.4 Mexico Computational Medicine and Drug Designing Software Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Computational Medicine and Drug Designing Software Consumption Value by Type (2019-2030)
7.2 Europe Computational Medicine and Drug Designing Software Consumption Value by Application (2019-2030)
7.3 Europe Computational Medicine and Drug Designing Software Market Size by Country
7.3.1 Europe Computational Medicine and Drug Designing Software Consumption Value by Country (2019-2030)
7.3.2 Germany Computational Medicine and Drug Designing Software Market Size and Forecast (2019-2030)
7.3.3 France Computational Medicine and Drug Designing Software Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Computational Medicine and Drug Designing Software Market Size and Forecast (2019-2030)
7.3.5 Russia Computational Medicine and Drug Designing Software Market Size and Forecast (2019-2030)
7.3.6 Italy Computational Medicine and Drug Designing Software Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Computational Medicine and Drug Designing Software Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Computational Medicine and Drug Designing Software Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Region
8.3.1 Asia-Pacific Computational Medicine and Drug Designing Software Consumption Value by Region (2019-2030)
8.3.2 China Computational Medicine and Drug Designing Software Market Size and Forecast (2019-2030)
8.3.3 Japan Computational Medicine and Drug Designing Software Market Size and Forecast (2019-2030)
8.3.4 South Korea Computational Medicine and Drug Designing Software Market Size and Forecast (2019-2030)
8.3.5 India Computational Medicine and Drug Designing Software Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Computational Medicine and Drug Designing Software Market Size and Forecast (2019-2030)
8.3.7 Australia Computational Medicine and Drug Designing Software Market Size and Forecast (2019-2030)
9 South America
9.1 South America Computational Medicine and Drug Designing Software Consumption Value by Type (2019-2030)
9.2 South America Computational Medicine and Drug Designing Software Consumption Value by Application (2019-2030)
9.3 South America Computational Medicine and Drug Designing Software Market Size by Country
9.3.1 South America Computational Medicine and Drug Designing Software Consumption Value by Country (2019-2030)
9.3.2 Brazil Computational Medicine and Drug Designing Software Market Size and Forecast (2019-2030)
9.3.3 Argentina Computational Medicine and Drug Designing Software Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Computational Medicine and Drug Designing Software Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Computational Medicine and Drug Designing Software Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Country
10.3.1 Middle East & Africa Computational Medicine and Drug Designing Software Consumption Value by Country (2019-2030)
10.3.2 Turkey Computational Medicine and Drug Designing Software Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Computational Medicine and Drug Designing Software Market Size and Forecast (2019-2030)
10.3.4 UAE Computational Medicine and Drug Designing Software Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Computational Medicine and Drug Designing Software Market Drivers
11.2 Computational Medicine and Drug Designing Software Market Restraints
11.3 Computational Medicine and Drug Designing Software Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Computational Medicine and Drug Designing Software Industry Chain
12.2 Computational Medicine and Drug Designing Software Upstream Analysis
12.3 Computational Medicine and Drug Designing Software Midstream Analysis
12.4 Computational Medicine and Drug Designing Software Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Entelos
Crown Bioscience
Chemical Computing Group
Nimbus Therapeutics
Schrodinger
Dassault Systemes
Genedata
Biognos
Leadscope
Rhenovia Pharma Limited
Compugen
Certara LP
Prosarix
Simulations Plus
Strand Life Sciences
听
听
*If Applicable.